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Objective(s): Recently cell therapy is a promising therapeutic modality for many types of disease 
including acute kidney injury (AKI). Due to the unique biological properties, mesenchymal stem cells 
(MSCs) are attractive cells in this regard. This study aims to transplant MSCs equipped with nuclear 
factor E2-related factor 2 (Nrf2) in rat experimental models of acute kidney and evaluate regeneration 
potential of injured kidney especially expression of injury and repaired biomarkers. 
Materials and methods: Nrf2 was overexpressed in bone marrow-derived MSCs by pcDNA.3.1 plasmid. 
AKI was induced using glycerol in rat models. The regenerative potential of Nrf2-overexpressed MSCs 
was evaluated in AKI-Induced animal models using biochemical and histological methods after 
transplantation. Expression of repaired genes, AQP1 and CK-18, as well as injury markers, Kim-1 and 
Cystatin C, was also assayed in engrafted kidney sections.  
Results: Our results revealed that transplantation of Nrf2-overexpressed MSCs into AKI-induced rats 
decreased blood urea nitrogen and creatinine and ameliorated kidney regeneration throughout 14 
days. Upregulation of repaired markers and downregulation of injury markers were considerable 14 
days after transplantation.   
Conclusions: Overexpression of Nrf2 in MSCs suggests a new strategy to increase efficiency of MSC-
based cell therapy in AKI. 
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Introduction 
Acute kidney injury (AKI) is the state of abrupt 
decrease in renal filtration function that leads to the 
accumulation of nitrogenous wastes in blood and 
loss of fluid, electrolyte and acid-base balance. In 
developed countries, it is estimated that 15% of 
adults admitted to hospitals develop AKI (1). AKI-
associated mortality is estimated as 50% in 
hospitalized patients, and 70-80% in patients under 
intensive care (2). 
The causes of acute renal failure are complex. 
Apoptosis, necrosis, inflammation and oxidative 
stress are the cellular and molecular events that lead 
to the end stage renal failure. Many risk factors have 
also been identified for the development of AKI 
including hypotension, pulmonary disease, liver
failure, sepsis, hypovolemia, increased age, 
hypertension, pre-existing renal disease, some 
hyperplasias, hypercalcemia, impaired cardiac output 
or heart failure, chemotherapy insults and many other 
medical conditions (3, 4). 
Currently, no available therapeutic options exist 
for decreasing the mortality rate caused by AKI. 
Kidney transplant is an alternate option but it is 
limited by organ transplantation problems. It is, 
therefore, very important to find other therapeutic 
options to restore renal function (5). In recent years, 
the use of mesenchymal stem cells (MSCs) is 
considered as a promising tool for cell therapy of 
AKI. Several in vitro and animal studies showed that 
MSCs can restore renal function after induced kidney 
injury (6-8). The effects of MSCs in tissue regeneration 
 
*Corresponding author: Sasan Saki. Department of Medical Laboratory Sciences, Faculty of Medical sciences, Islamic Azad University, Arak Branch, Arak, 
Iran. Tel: +086-33412508; email: S-saki@iau-arak.ac.ir 
 Zhaleh et al                       Nrf2-overexpressed-MSC and renal regeneration 
   
    Iran J Basic Med Sci, Vol. 19, No. 3, Mar 2016 
 
324 
tie with trans-differentiation of MSCs to organ 
specific cells and secretion of soluble factors that 
improve cell survival and restore damaged tissue.  
Furthermore, clinical studies in phase I and II 
assess the safety and efficacy of MSCs in patients 
with AKI (7, 9, 10). This preliminary data on safety 
and potential role of MSCs in the treatment of acute 
renal failure together with intrinsic properties of 
MSCs obtained in large numbers from various 
sources and their capacity to differentiate into other 
cell types as well as low immunogenesity make them 
a reliable candidate for the treatment of acute renal 
failure (11). However, low viability of MSCs hampers 
their application in clinical trials. Hence, equipping of 
MSCs against various stressful conditions might 
enhance their therapeutic potentialities (12). In this 
regard, overexpression of the nuclear factor erythroid-2 
related factor 2 (Nrf2) in MSCs protects them against 
cell death and apoptosis which is triggered by hypoxic 
and oxidative stress conditions (13).  
Nrf2 is a transcription factor that binds to the 
promoter region of several detoxification and 
antioxidant genes and upregulate the expression of 
these genes to protect cells against oxidative stress-
induced injuries in the cells. It has been shown that 
Nrf2 protects different cell types and organs from 
toxic agents and pathogens (14, 15). Also, Nrf2 acts 
as a major factor to ameliorate oxidative stress and 
inflammation in renal injuries (16, 17).  
In this study, we investigated whether Nrf2 
overexpression in MSCs shows higher protective 
effects especially in terms of expression of molecular 
injuries/repairs markers in glycerol-induced AKI 
models of rats than non-recombinant MSCs.  
 
Materials and Methods 
Isolation of MSCs and cell culture  
MSCs were prepared from rat bone marrow (4–6 
weeks old) as described previously (18). Then, the cells 
were cultured in culture medium containing dulbecco’s 
modified eagle’s medium-low glucose (Gibco, USA) 
supplemented with 10% fetal bovine serum (Gibco, 
USA), 1% penicillin and streptomycin (Gibco, USA). 
Culture flasks were kept at 37 °C in a humidified 
atmosphere containing 5% CO2. Fresh complete 
medium was replaced every 2 or 3 days. In order to 
characterize the ex vivo-expanded MSCs, they were 
analyzed by flowcytometry for the expression of 
surface markers as described previously (18). 
 
Nrf2 expression plasmid construction and MSCs 
transfection 
To construct the pcDNA 3.1-Nrf2 recombinant 
vector, the full-length human Nrf2 cDNA was     
amplified through RT-PCR using specific forward 5’ -
CACCATGGGAATGGACTTGGAGCTGCC-3’ and reverse 5’ 
CTAGTTTTTCTTAACATCTGGCTTCTTAC-3’ primers. 
Two restriction sites EcoRІ and BamHІ were added at 
both end of the gene respectively. The Nrf2 gene was 
cloned into the EcoRI and BamHІ restriction sites of 
the mammalian expression vector pcDNA3.1 
(Invitrogen, USA). DNA sequencing was performed to 
verify the fidelity of cloning. MSCs were transfected 
with pcDNA 3.1-Nrf2 plasmid by FuGENE HD (Roche, 
Germany) transfection reagent following the 
manufacturer's protocol. The expression level of 
Nrf2 was evaluated by RT-PCR, and Western blot 
analysis.  
 
RT-PCR and Western blot analysis 
To assess the expression of Nrf2 by reverse 
transcriptase polymerase chain reaction (RT-PCR), total 
RNA was isolated from both recombinant pcDNA 3.1-
Nrf2 t transfected-MSCs (MSC-Nrf2) and normal MSCs 
using TriPure reagent (Roche, Germany). Then, the 
total RNA was used to construct cDNA using first strand 
cDNA synthesis superscript kit (Invitrogen, USA) 
according to the manufacturer's protocol. PCR was 
performed using internal primers forward:  
5’ GCGACGGAAAGAGTATGAGCTGG3’ and reverse: 5’ 
GTTGGCAGATCCACTGGTTTCTG3’.  
Western blot analysis was performed to detect the 
expression of Nrf2 protein. Samples were run on 10% 
SDS-polyacrylamide gel, and then transblotted onto the 
PVDF membrane (Roche, Germany) followed by 
blocking and 3 hr incubation at 4 °C with specific 
primary antibodies, i.e., anti-β-actin (Sigma, USA) or 
anti-Nrf2 antibodies (Santa Cruz, USA). Afterwards, the 
membranes were washed with tris-buffered saline 
containing 0.1% Tween 20 and incubated with 
secondary horse raddish peroxidase-conjugated 
antibody (Sigma, USA). Finally, chemiluminescence 
solution was used to visualize the expected protein 
bands on the PVDF membrane. 
 
Induction of experimental models of AKI in rat 
Animal experiments were conducted in accordance 
with the NIH guide for the care and use of laboratory 
animals. All protocols were conducted in accordance 
with the ethic committee of Iranian Blood Transfusion 
Organization (IBTO). Male 6-week-old Rattus 
norvegicus weighing 160-180 grams (g) were fed with 
normal chow and also allowed to free excess of water. 
AKI was induced by intramuscular injection of 5, 8, 10, 
13 and 15 ml/Kg glycerol (50%) (Sigma, USA). After 24 
hr, water-deprived animals were anesthetized and 
injected with different doses of glycerol into the left and 
right hind femoral muscles. Injection of glycerol 
induced kidney injury was evaluated by analyzing the 
levels of blood urea nitrogen (BUN) and serum 
creatinine (SCr) along with histological analysis of the 
kidney sections for interval times (24, 48 and 72 hr)  
 
MSCs transplantation  
The rats were divided into five groups: i) AKI 
group  (n = 10), ii) AKI/PBS group which were AKI-
induced rats received PBS (n=10), iii) AKI/MSC 
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group which were AKI-induced rats received normal 
MSCs (n=10), iv) AKI/MSC-V group which were AKI-
induced rats received transfected-MSCs with empty 
pcDNA3.1 vector (MSC-V) (n = 10) and v) AKI/MSC-
Nrf2 group which were AKI-induced rats received 
transfected-MSCs with recombinant pcDNA3.1-Nrf2 
vector (MSC-Nrf2) (n=10). Normal rats which 
received PBS were considered as control (Cont.). 
MSC-Nrf2, MSC-V and MSCs were administered to 
AKI-induced rats 24 hr after induction of AKI. 
1.5×106 of these mentioned cells were suspended in 
300 µl of PBS, and then intravenously injected to the 
rats. Blood samples were collected from rats to 
determine the level of BUN and SCr on the 3th, 7th and 
14st days (19). After 14 days, rats were sacrificed 
according to the ethical principles for animal 
research, and the kidney tissues were collected to go 
through RT-PCR and histological techniques.  
 
Renal function analysis 
To analyze the renal function of AKI-induced and 
transplanted rats, blood samples were collected from 
the intracardiac punctures of anesthetized rats after 
induction of AKI and cell therapy. The animals were 
anesthetized using ketamine (100 mg/kg) and xylazine 
(10 mg/kg). The levels of BUN and SCr were measured 
with BUN and SCr assay kits (Biosystem, Spain) using 
an automatic analyzer (BT 3000 PL/S, Italy).  
 
Histological analysis of kidney tissue  
Kidney tissues were fixed in 4% paraformaldehyde, 
dehydrated in graded concentrations of alcohols, and 
then embedded in paraffin. Next, the tissues were cut 
into 5-μm sections and stained with hematoxilin and 
eosin (Sigma, USA). Luminal hyaline casts and tubular 
necrosis (cell debris in tubular lumen, denudation of 
tubular basement membrane and nuclear 
fragmentation) were assessed and scored according to 
six levels based on the percentage of tubule affection 
under a high-power field (HPF) using a light 
microscope. 
 
RT-PCR and real-time RT-PCR analysis of kidney 
sections 
To evaluate the effects of MSCs transplantation on 
the expression of renal biomarkers in kidney tissues, 
RNA was extracted from renal tissue and cDNA was 
synthesized. RT-PCR was performed to evaluate 
expression of repaired genes: aquaporin 1 (AQP1) and 
cytokeratin-18 (CK-18); injury biomarkers: kidney 
injury molecule-1 (Kim-1) and Cystatin C. Quantitative 
real-time RT-PCR was also performed using SYBR 
green master mix (Takara, Japan). Reactions were 
performed in triplicate with Rotor-gene RG-3000 
(Corbett, Germany), the specificity was monitored using 
melting curve analysis after cycling and the ΔCt was 
calculated automatically. β-actin was used as 
normalizer.  
Results 
Characterization of MSCs 
MSCs were isolated from bone marrow through 
their adhesion to tissue culture surfaces. In order to 
evaluate the rat MSCs phenotype, cell-surface 
antigens were analyzed by flow cytometry. These 
cells revealed the typical cell-surface antigens of 
MSCs, and were positive for CD44, CD105and CD29 
antigens, while they were negative for hematopoietic 
antigens i.e., CD45 and CD34 (18).  
 
Nrf2 was overexpressed in MSC-Nrf2  
Three days post-transfection of the MSCs with the 
recombinant pCDNA3.1-Nrf2 plasmid, the over 
expression of Nrf2 gene was analysed by RT-PCR. In 
contrast to the normal MSCs which revealed no Nrf2 
mRNA expression, over expression of Nrf2 was 
detected in MSC-Nrf2 that transfected with 
pCDNA3.1-Nrf2 (Figure 1A). The overexpression of 
the Nrf2 protein was also detected in these cells by 
western blotting, while no detectable amount of Nrf2 
protein was found in normal MSCs (Figure 1B).  
 
Glycerol induced AKI in rat experimental models 
Intramuscular administration of different doses 
of glycerol (50%) caused AKI in rats.  Elevations in 
BUN was considerable 24 hr after injection of 8 
ml/Kg of glycerol in comparison to control that no 
received any glycerol (400±10 mg/dl, versus 21±6 
mg/dl, p≤0.001) (Figure 2A). SCr level was also 
significantly increased in 8 ml/Kg glycerol-received 
rats (4.5±0.2 mg/dl) in compared with control      
(0.3 ± 0.1 mg/dl, P≤0.001) (Figure 2B). 
Histological analysis of the kidney sections 
verified the tubular necrosis, casts, and loss of brush 
border 24 hr after injection of 8 ml/kg glycerol 
(Figure 2C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Overexpression of Nrf2 in transfected MSCs with the 
recombinant vector Nrf2-pcDNA 3.1; A. RT-PCR analysis of MSCs 
72 hr after transfection. MSCs transfected with Nrf2-pcDNA 3.1 
(MSC-Nrf2) expressed Nrf2, but detectable expression of Nrf2 was 
not observed in non-manipulated MSCs as the control group.        
β-actin was used for normalization; B. Western blot analysis of 
transfected cell. MSC-Nrf2 expressed Nrf2 protein 
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Figure 2. Confirmation of acute kidney injury (AKI) induction in rat 
models. A. Biochemical analysis of blood urea nitrogen (BUN) 24, 48 
and 72 hr after intramuscular injection of different glycerol doses. B. 
Biochemical analysis of serum creatinine (SCr) 24, 48 and 72 hr after 
intramuscular injection of different glycerol doses. BUN and SCr were 
significantly higher in 8 ml/Kg glycerol-received rats for 24 hr in 
comparison with control (those without any injection) (*** P≤0. 001). 
C. Histological analysis of kidney tissue 24 hr after intramuscular 
injection of 8 ml/kg glycerol. Tubular necrosis (-), casts (+), and loss of 
brush border (*) indicated kidney injury in glycerol-received rates. 
Considering the fact that Injection of high glycerol doses (10, 13, and 
15 ml/Kg) led to more death in rat models, 8 ml/Kg of glycerol was 
selected as the optimized AKI-inducing dose 
 
Administration of 10, 13 and 15 ml/kg glycerol 
led to death of the rats after 72 hr. Therefore,                         
8 ml/kg of glycerol after 24 hr was considered the 
optimized dose and time for induction of AKI in rats.  
 
MSC-Nrf2 transplantation improves renal function in 
glycerol-induced AKI rats 
To investigate the efficacy of MSC transplantation in 
improving renal function, the BUN and SCr 
concentrations was evaluated in MSC and MSC-Nrf2-
received groups (AKI/MSC and AKI/MSC-Nrf2) as well 
as  AKI/PBS group which received PBS (sham group) 
after 3, 7 and 14 days along with controls.  
On days 7th and 14th after cell therapy, the BUN and 
SCr levels decreased in cell therapy groups. The BUN 
levels of AKI/MSC-Nrf2 which transplanted with Nrf2 
overexpressed-MSCs were decreased significantly 
compared to that of AKI/MSC which transplanted with 
normal MSCs during 14 days after transplantation 
(P≤0.01 and p≤0.001) (Figure 3A). Interestingly, over-
expression of Nrf2 in MSCs increased the protective 
effect of MSCs, and the levels of SCr dropped off more in 
rats treated by MSC-Nrf2 in comparison to those of 
transplanted with MSCs (p≤0.05 and p≤0.01) (Figure 
3B). These results verify the role of Nrf2 over-
expression to improve efficacy of MSC cell therapy for 
improvement of renal function in glycerol-induced 
renal injury. 
 
Nrf2 increase the re-construction potential of MSCs 
in animal models of AKI 
Kidney tissue was collected on days 14th after cell 
therapy. Histological analysis of the kidney sections 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Evaluation of MSCs therapeutic potentialities in AKI-
induced rats using biochemical analysis. Serum samples were 
collected 3, 7, and 14 days after transplantation of different MSC 
groups in AKI-induced rats. A.  BUN serum level significantly dropped 
off in AKI/MSC-Nrf2 group transplanted with MSC-Nrf2 in comparison 
to those transplanted with MSCs (AKI/MSC). B. SCr serum level was 
also much lower in AKI/MSC-Nrf2 compared to other groups. AKI: 
AKI-induced rats without any injection, AKI/MSC-V: AKI-induced rats 
transplanted with empty vector transfected-MSCs, AKI/PBS: AKI-
induced rats injected with PBS, Control: normal rat with no treatment 
(*** P≤0. 001, ** P≤0. 01 and * P≤0.05) 
 
verified that MSC and MSC-Nrf2-treated groups were 
recovering in comparison with the group receiving 
PBS. The degree of micro aggregate-like degeneration 
and necrosis of renal tubular epithelial cells were 
lower in AKI/MSC and AKI/MSC-Nrf2 rats compared 
with the AKI group (Figure 4 A, B and C). Next, to 
evaluate the effects of MSCs on the proliferation of 
tubular cells in AKI models, the number of casts and 
tubular necrosis were estimated per field. In AKI/MSC 
and AKI/MSC-Nrf2 groups, the number of both the 
cast and    tubular necrosis was lower than those of 
AKI group (Figure 4D).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Evaluation of MSCs therapeutic potentialities in AKI-induced 
rats using histological analysis.  Kidney sections were prepared to 
assess kidney regeneration 14 days after transplantation of different 
MSCs groups in AKI-induced rats.  A.  AKI/PBS group transplanted 
with PBS showed more casts and tubular necrosis. B. AKI/MSC group 
transplanted with normal MSCs indicated partial kidney regeneration. 
C. Rare casts and tubular necrosis were observed in AKI/MSC-Nrf2 
group that was transplanted with Nrf2 overexpressed MSCs. D. 
Quantification of histological analysis results. Casts and tubular 
necrosis significantly decreased in AKI/MSC-Nrf2 in comparison to 
AKI/MSC group (** P≤0. 01 and * P≤0.05) 
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However, in AKI/MSC-Nrf2 group, the tubular cells 
show higher proliferation rate, and the number of casts 
decreased significantly over 14 days (P≤0.05 and 
P≤0.01) (Figure 4D). These results indicate the 
successful engraftment of MSCs in injured kidneys that 
decrease the severity of injuries and repair the 
damaged tissue, and also more improvement in 
AKI/MSC-Nrf2 group confirmed the successful function 
and resistance of Nrf2-MSCs.  
 
MSC-Nrf2-based cell therapy increases repaired 
genes and decreases injury biomarkers in AKI 
The expression of AQP1, CK-18 as repaired genes 
and Kim-1 and Cystatin C as injury biomarkers was 
assayed by RT-PCR. Two weeks after cell therapy, the 
results of RT-PCR revealed low expression of AQP1 
and CK-18 in AKI, AKI/MSCs and AKI/MSC-V groups. 
However, rats engrafted with MSC-Nrf2 indicated a 
high level of both AQP1 and CK-18 expressions. 
Conversely, the expression of Kim-1 and Cystatin C 
enhanced in AKI group (Figure 5A). This finding was 
further confirmed by real-time RT-PCR analysis. 
Expression of AQP1, CK-18 was significantly up-
regulated in AKI/MSC-Nrf2 (P≤0.05) (Figure 5B). 
Engraftment of MSC-Nrf2 into AKI-induced rat 
models down-regulated the expression levels of 
injury biomarkers in AKI/MSC-Nrf2 in comparison to 
AKI/MSC groups (P≤0.001) (Figure 5C). Taken 
together, the increase in repaired genes and parallel 
decrease in injury biomarkers of AKI/MSC-Nrf2 
groups indicate the beneficial role of Nrf2 in the 
regenerative process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Evaluation of biomarkers of kidney injury in different rats 14 
days after cell therapy. Expression of AQP1 and CK-18 (as repaired 
genes) and Kim-1 and Cystatin C (as injury biomarkers) was assayed 
in transplanted rats along with control group. A. RT-PCR analysis 
results indicated that AKI/MSC-Nrf2 up-regulated AQP1, CK-18 and 
down- regulated Kim-1, Cystatin C in comparison with other groups. B. 
Quantitative real time RT-PCR analysis of the repaired genes in 
different transplanted rats. Expression of AQP1 and CK-18 was 
significantly higher in AKI/MSC-Nrf2 than that of in AKI/MSC.                
C. Quantitative real time RT-PCR analysis of injury biomarkers in 
different transplanted rats.  Expression of Kim-1 and Cystatin C was 
down regulated in AKI/MSC-Nrf2 (*** P≤0. 001 and * P≤0.05) 
 
Discussion 
Ischemia, nephrotoxic insults and hypoxia are main 
underlying causes contributing to AKI, a condition in 
which renal cells are damaged, and finally results in 
rapid decrease in glomerular filtration rate. AKI is 
associated with unacceptably high mortality rate (2-4). 
No effective therapeutic option has been identified for 
AKI, and supportive measures had no chance in 
decreasing the mortality rates. Therefore, finding new 
therapeutic options to manage AKI is of critical 
importance. In recent years, mesenchymal stem cells 
(MSC) are considered as a promising therapeutic option 
for AKI. Many studies indicate the potential role of 
MSCs in inducing regeneration responses that result in 
tissue repair and restoring renal function after AKI            
(6-8).  
In current study, we up-regulated Nrf2, one of the 
main transcription factors of cell antioxidant 
defense, in MSCs at transcriptional as well as 
translational level using transfection reagent that 
decrease the concerns about using of viral vector in 
preclinical and clinical studies. Nuclear factor-
erythroid-2-related factor 2 (Nrf2) plays a central 
role in natural antioxidant defense system that 
controls the induction of several antioxidant and 
detoxifying proteins such as catalase, SOD,        
NAD(P) H quinone oxidoreductase-1 (NQO1), heme 
oxygenase-1(HO-1), glutamate cysteine ligase, 
glutathione S-transferase, glutathione peroxidase 
and thioredoxin (20). Therefore, Nrf2 plays a central 
role in the regulation of cellular antioxidant and   
anti-inflammatory responses and defend against 
oxidative stress (21).  
We induced AKI in rat after injection of 8 ml/kg of 
for 24 hr. Then, the therapeutic efficacy of these Nrf2-
overexpressed-MSCs was assessed by measuring BUN 
and creatinine concentration and histological analysis 
in compared with proper controls. To further verify the 
results, we assessed the expression of other molecular 
biomarkers. Our result revealed that transplantation of 
Nrf2 overexpressed-MSCs increase the expression of 
repaired genes such as AQP-1 and CK-18, and 
simultaneously down-regulates the expression of injury 
biomarkers i.e., Kim-1 and Cystatin C. These mentioned 
genes are known as new biomarkers for determination 
of renal function or injury (22-24) 
The therapeutic effects of MSCs is mainly through 
paracrine anti-apoptotic, mitogenic, anti-inflammatory 
and immune-modulating influences leading to promote 
epithelial proliferation, modulate inflammation, or 
enhance angiogenesis (25, 26). It has been shown that 
after MSC infusion, pro-inflammatory cytokines such as 
IL-6 and TNF-α decreased, and in parallel, anti-
inflammatory cytokines such as IL-10 increased (27, 
28). Furthermore, MSCs release a variety of growth 
factors such as vascular endothelial growth factor 
(VEGF), insulin-like growth factor-1 (IGF-1), 
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hepatocyte growth factor (HGF) that help to tubular 
regeneration and renal recovery after AKI (27, 29). 
Several studies investigated the mechanisms to 
make MSCs more resistant against the environment 
which they are supposed to be transplanted (12).  
Mohammadzadeh et al (2015) reported that Nrf2-
overexpressed MSCs ameliorated kidney regeneration 
in Cisplatin-AKI-induced rats. They used Gat way 
technique and transducted MSCs with adenovirus viral 
vector to over express Nrf2 in them. They evaluated 
therapeutic potentialities of manipulated-MSCs 11 days 
after transplantation using biochemical and 
pathological methods. They did not assay the 
expression of repaired genes such as AQP-1 and CK-18, 
and down-regulation of injury biomarkers, Kim-1 and 
Cystatin C (30). 
Liu and colleagues administrated MSCs in 
combination with erythropoietin (EPO) to improve 
the repair effects of these cells in AKI-induced mice. 
This strategy resulted in fast reduction in serum BUN 
and creatinine along with pathological changes in 
tubular cells. They showed that the expression of CK-
18 was significantly up regulated in the renal cell 
after transplantation of MSCs in combination with 
EPO (31). 
In another study, Masoud et al enhanced in vitro 
proliferation and survival of MSCs by 6 hours-
preconditioning with S-nitroso N-acetyl penicillamin. 
They transplanted these preconditioned-MSCs into 
ischemia–reperfusion-induced AKI rats. According to 
their results, the creatinine clearance and in vivo 
engraftment was improved and fibrosis was 
decreased due to enhanced homing of transplanted 
preconditioned-MSCs (5). Lee et al compared the 
effect of weekly (up to 5 weeks) administration of 
bone marrow-MSCs with the effect of once injection 
of these unique cells in restoration of injured kidney 
tissue. They indicated that urinary protein excretion, 
systolic blood pressure, and serum creatinine level 
obviously improved in remnant kidney injury after 
repeated MSCs injection (32). There are several 
studies that conducted to employ MSCs with or 
without any manipulation for treatment of kidney 
diseases. Reported results might be various because 
of different methodology.  
 
Conclusion 
In summary, we showed that MSC-Nrf2 cell therapy 
improves renal function and regeneration following 
glycerol-induced renal injury. Moreover, Nrf2 
overexpression potentiates MSCs against stress-related 
environment in vivo. 
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